CS MEDICA receives order from Alsitan – Alsitan expands their product portfolio
CS MEDICA A/S (”CS MEDICA” or the ”Company”) announces today that the Company has received an order from Alsitan GmbH (“Alsitan”). The order includes a new advanced arthritis pain gel under a private label for the German territory. The order amounts to 15,000 units and corresponds to an order value of DKK 0,56 million in revenue.
Lone Henriksen, CEO CS MEDICA, comments
“Alsitan has had a very successful market reception of the arthritis gel in the German market and is now expanding their portfolio with another white label CANNASEN product - a new advanced arthritis pain gel. Together with Alsitan, who are experts in their field, this order gives us a unique opportunity to better match our product portfolio to the market dynamics. We see this not only as proof of concept, but also proof of business.”
Alsitan GmbH
Alsitan, the Company’s white label distributor in German, is a private label company focused on developing natural medicines and food/nutritional supplements to maintain physical and emotional health. Alsitan was founded in 1949 and is headquartered in Greifenberg, Germany.
CS MEDICA’s Arthritis Pain Gel will be introduced to the market under the brand name “Alsiroyal”, sold by Alsitan.
About Arthritis Pain Gel
The Arthritis Gel is a patent-pending, Medical Device class I, a topical treatment for body areas affected by pain and or arthritis. It relieves the painful conditions of hot and swollen joints. The gel has a proven efficacy via a preclinical study and clinical trials.
This disclosure contains information that CS MEDICA A/S is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 16-09-2022 17:23 CET.
For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@cs-medica.com
Website: https://www.cs-medica.com/
CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.
The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.
Tags: